Home > Healthcare > Medical Services > Biodefense Market

Biodefense Market Share

Report ID: GMI714
Published Date: Apr 2022
Report Format: PDF

Download Free Sample

Biodefense Market Share

Some of the key market players operating in the biodefense industry include

Alexeter Technologies, LLC
Altimmune
ANP Technologies
Bavarian Nordic
BioFire Defense (bioMérieux SA)
Biosearch Technologies
Bruker Detection
Electronic Sensor Technology Inc.
Elusys Therapeutics
Emergent BioSolutions
Ichor Medical Systems, Inc.
Nanologix
New Horizon Diagnostic Corp.
PositiveID Corporation
SIGA Technologies
Smiths Detection Group Ltd.
Synexis Systems

These market players are employing a variety of development strategies, including continual innovation and technological advancements, in order to maintain business rivalry in the biodefense market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Biodefense industry revenue was valued at around USD 15.6 billion in 2021 and is anticipated to exhibit an 8.7% CAGR between 2022 and 2028 driven by several safety measures initiated by the government across the developed countries.

Biodefense is a combination of several processes and systems that are put in place by customs agents, bioscience laboratories, among other professionals to prevent the usage of dangerous pathogens and toxins.

The vaccines product segment accounted for over 64.5% of the biodefense market share in 2021 owing to their rising production rate to prevent the spread of various viruses.

North America held around 41.6% of the biodefense business revenue share in 2021 and is pegged to observe a notable CAGR through 2028 led by the escalating threat of harmful biological materials.